Fig 1. Percentage (number) of ceftriaxone-resistant isolates among invasive non-typhoidal Salmonella cases identified in malaria vaccine trial (vaccine trial; 2009–2013), central nervous system infection study (CNS study; 2012–2013), and International Emerging Infections Program (surveillance program; 2009–2014), Siaya county, Kenya.